Biocon Biologics Ltd launches biosimilar HULIO in US

HULIO meets the rigorous biosimilar approval standards of the FDA. Like Humira, HULIO is citrate-free and is made without natural rubber latex (to help reduce hypersensitivity reactions). Biocon Biologics also offers HULIO360, a robust patient support programme, which includes benefits verification and prior authorisation support, copay assistance, a bridge programme for eligible patients, and at-home nurse injection training.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/6dFyqXN
via